Intelligence · Clinical Pipeline
Disc Medicine Pipeline
All ClinicalTrials.gov programs at Disc Medicine — phase, modality, and trial IDs.
- Programs
- 106
Quick answer
Disc Medicine has 106 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Tiragolumab, Tecentriq 1 200 mg concentrate for solution for infusion
Disc Medicine
HNSCC, metastatic deficient mismatch repair (dMMR)/MSI-high (MSI-H) tumors, irresectable or metastatic melanoma, locally advanced or metastatic solid tumor
1 trial -
YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.
Disc Medicine
castration-resistant prostate cancer
1 trial -
Zr89
Disc Medicine
giant cell arteritis, rheumatoid arthritis
1 trial -
[18F]-olaparib PET; Molecular imaging of DNA damage response by [18F]-olaparib PET
Disc Medicine
Head and neck squamous cell carcinoma (HNSCC)
1 trial -
[18F]Fluor-PEG-Folate
Disc Medicine
giant cell arteritis
1 trial -
[18F]Tetrafluoroborate
Disc Medicine
Differentiated Thyroid Cancer
1 trial -
[68Ga]FAPI-46
Disc Medicine
giant cell arteritis - polymyalgia rheumatica spectrum disease
1 trial -
[68Ga]Ga-PentixaFor
Disc Medicine
Cardiac Sarcoidosis
1 trial -
cRGD-ZW800-1
Disc Medicine
Oral cancer
1 trial -
cRGD-ZW800-1
Disc Medicine
Squamous cell carcinoma of the larynx and hypopharynx
1 trial
Frequently asked questions
How many pipeline programs does Disc Medicine have?
106 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs